Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial and intravenous use. It enhances radiographic imaging in diagnostic procedures for patients undergoing angiography, CT scans, and urography.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron (iomeprol) is employed in diagnostic radiographic procedures that require enhanced vascular and tissue contrast.

Angiography: provides clear visualization of blood vessels and improves detection of vascular lesions. CT imaging: enhances delineation of anatomical structures and pathology during computed tomography scans. Urography: improves contrast of the urinary tract, aiding in the identification of stones, tumors, and structural abnormalities.

Iomeron may be associated with a range of adverse reactions, ranging from mild and transient to severe.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste in the mouth. - Mild nausea or vomiting. - Headache. - Transient itching or urticaria. - Mild hypotension.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Severe hypotension or cardiovascular collapse. - Pulmonary edema. - Persistent severe skin reactions such as Stevens‑Johnson syndrome. - Thyroid dysfunction due to iodine load.

Prior to administering Iomeron, clinicians should observe several precautionary measures to minimize risk. - Assess renal function: evaluate serum creatinine and eGFR before use. - Review allergy history: identify prior reactions to iodinated contrast agents. - Ensure adequate hydration: encourage fluid intake or intravenous hydration when appropriate. - Discontinue metformin in at‑risk patients: hold metformin in those with impaired renal function. - Monitor thyroid status: consider thyroid function tests in patients with known thyroid disease. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with certain medications and substances, affecting safety or efficacy.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in patients with reduced renal clearance. - Thyroid hormone preparations (levothyroxine, liothyronine): excess iodine may alter thyroid hormone levels. - Radiopharmaceuticals: iodine load can interfere with uptake of certain nuclear imaging agents.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may increase risk of contrast‑induced nephropathy. - Diuretics: can exacerbate renal impairment when combined with contrast. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may heighten renal toxicity. - Calcium channel blockers: monitor blood pressure as contrast may cause hypotension.